Yayın:
Development of microparticles containing polylactic acid/Bioactive glass/Caffeic acid for bone tissue engineering

dc.contributor.authorTag, Beyda
dc.contributor.authorNouri, Sabereh
dc.contributor.authorAyran, Musa
dc.contributor.authorTiryaki, Aysegul
dc.contributor.authorUlag, Songul
dc.contributor.authorDalbayrak, Basak
dc.contributor.authorYuka, Selcen Ari
dc.contributor.authorArisan, Elif Damla
dc.contributor.authorEkren, Nazmi
dc.contributor.authorUstundag, Cem Bulent
dc.contributor.authorGunduz, Oguzhan
dc.date.accessioned2026-06-27T15:26:03Z
dc.date.issued2025
dc.description.abstractBone defects from trauma, fractures, infections, or neoplasms present a significant challenge, driving the need for advanced bone tissue engineering methods. This study combines caffeic acid and bioactive glass in a microparticle system to enhance their synergistic effects and boost bone regeneration by leveraging's role in cell proliferation and differentiation and osteoconductive properties of bioactive glass. Within the scope of the study, microparticles were produced via electrospray method for four different formulations: 3% polylactic acid, 3% PLA/0.1% bioactive glass, 3% PLA/0.1% caffeic acid, and 3% PLA/0.1% bioactive glass /0.1% caffeic acid. Structural characterizations of microparticles were assessed using SEM, FTIR, DSC, and XRD, while caffeic acid release profiles and biocompatibility with hFOB cells were also evaluated. Structural analyses showed that the average diameter of solely PLA microparticles of 3,54 mu m +/- 0.58 mu m could be increased up to 4.33 mu m with bioactive glass and caffeic acid. Thermal analysis indicated that bioactive glass and caffeic acid had a minimal impact on thermal properties, and in vitro tests showed bioactive glass extended caffeic acid release time by up to four times. Biocompatibility tests confirmed no cytotoxicity to hFOB cells, highlighting the potential of Polylactic acid/Bioactive glass/Caffeic acid microparticles for improving bone regeneration.en
dc.description.urihttps://doi.org/10.1007/s00289-025-06109-3
dc.identifier.doi10.1007/s00289-025-06109-3
dc.identifier.eissn1436-2449
dc.identifier.issn0170-0839
dc.identifier.issue2
dc.identifier.urihttps://hdl.handle.net/20.500.14981/70937
dc.identifier.volume83
dc.identifier.wos001636624900022
dc.language.isoeng
dc.publisherSPRINGER
dc.relation.ispartofPOLYMER BULLETIN
dc.subjectBioactive glass
dc.subjectBone defects
dc.subjectCaffeic acid, electrospray
dc.subjectMicroparticle
dc.subjectPolylactic acid
dc.subjectBIOACTIVE GLASS NANOPARTICLES
dc.subjectCAFFEIC ACID
dc.subjectDRUG-DELIVERY
dc.subjectINVOLVEMENT
dc.subjectPOLYMERS
dc.subjectMICRO
dc.subjectPolymer Science
dc.titleDevelopment of microparticles containing polylactic acid/Bioactive glass/Caffeic acid for bone tissue engineering
dc.typeArticle
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar